Скачать или смотреть Pharma, Power and Leverage | Why the World Depends on Indian Healthcare

Indian pharmaceutical companies are deeply embedded in global healthcare systems. From HIV treatment in Africa to Hepatitis C elimination programmes, from affordable cancer drugs to large-scale vaccine supply, Indian medicines have reshaped what is economically possible in global health.
In this episode of India Business Insights, we analyse how India’s pharmaceutical industry has become a source of soft power, strategic leverage, and global indispensability. Using concrete data and real examples, we examine how Indian generics collapsed HIV treatment costs by over 95 percent, how Indian firms drove down Hep C drug prices by 99 percent, how oncology treatments became affordable after Indian entry, and why WHO and UNICEF procurement systems are structurally dependent on Indian manufacturing.
We also explore why sanctions and trade pressure have natural limits in healthcare, why intellectual property pressure has ceilings, and how India’s growing role in complex generics, biosimilars, and drug discovery could further increase its strategic importance.
This is not a business success story. It is a structural analysis of how Indian pharma has become part of global health infrastructure and why the world cannot afford to destabilise it.




#IndianPharma
#GlobalHealthcare
#IndiaBusinessInsights
#PharmaPower
#SoftPower
#HealthcareGeopolitics
#IndiaGlobal
#PharmacyOfTheWorld